Risk factors for colorectal cancer following breast cancer

被引:23
作者
Kmet, LM
Cook, LS
Weiss, NS
Schwartz, SM
White, E
机构
[1] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada
[2] Alberta Canc Board, Div Epidemiol Screening & Prevent, Calgary, AB, Canada
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Serv, Seattle, WA 98104 USA
关键词
breast neoplasms; colorectal neoplasms; second primary neoplasms;
D O I
10.1023/A:1023926401227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To investigate risk factors for colorectal cancer following breast cancer. Methods. In this nested case-control study, all women (n=14,900) with a first primary breast cancer (1978-1992) were identified from the western Washington population-based Surveillance, Epidemiology, and End Results Cancer Registry. Cases (n=160) developed a second primary colorectal cancer before 1995, at least 6 months after the first cancer diagnosis. Controls (n=310, matched to the cases on calendar year, age and breast cancer stage) were randomly selected from those who did not develop a second primary cancer and who survived to the case's colorectal cancer diagnosis date. Characteristics of the cases and controls at initial diagnosis were compared using conditional logistic regression. Results. The incidence of colorectal cancer was associated with a family history of breast cancer (v.s. no family history, matched odds ratio (mOR)=2.1, 95% confidence interval (CI): 1.1-4.1), high body mass index (greater than or equal to30 kg/m(2) v.s. <30 kg/m(2), mOR=2.2, CI: 1.2-3.9), and lobular breast cancer histology (v.s. ductal, mOR=2.0, CI: 0.9-4.4). Risk was unrelated to menopausal status, prior hormone replacement therapy and estrogen/progesterone receptor status of the breast tumors. Conclusions. The risk of developing a second primary colorectal cancer may be elevated among certain subsets of breast cancer patients.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 42 条
[1]  
ADAMI HO, 1984, J NATL CANCER I, V73, P1049
[2]  
[Anonymous], 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
[3]  
[Anonymous], 1999, J NATL CANC I, V91, P1310
[4]   ADJUVANT CHEMOTHERAPY IN EARLY BREAST-CANCER AND INCIDENCE OF NEW PRIMARY MALIGNANCIES [J].
ARRIAGADA, R ;
RUTQVIST, LE .
LANCET, 1991, 338 (8766) :535-538
[5]  
BORDIN GM, 1977, CANCER, V40, P1793, DOI 10.1002/1097-0142(197710)40:4+<1793::AID-CNCR2820400804>3.0.CO
[6]  
2-7
[7]   2ND PRIMARY NEOPLASMS FOLLOWING BREAST-CANCER IN SAARLAND, GERMANY, 1968-1987 [J].
BRENNER, H ;
SIEGLE, S ;
STEGMAIER, C ;
ZIEGLER, H .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (10) :1410-1414
[8]  
Breslow NE, 1980, STAT METHODS CANC RE, P122
[9]   Incidence of second primary cancers in three Italian population-based cancer registries [J].
Buiatti, E ;
Crocetti, E ;
Acciai, S ;
Gafa, L ;
Falcini, F ;
Milandri, C ;
LaRosa, M .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1829-1834
[10]   Colorectal cancer following tamoxifen therapy for breast cancer (United States) [J].
Cook, LS ;
Weiss, NS ;
Pharris-Ciurej, N ;
Schwartz, SM ;
White, E .
CANCER CAUSES & CONTROL, 2001, 12 (05) :405-410